‘Pharma Bro’ in Solitary Confinement for Alleged Phone Use

Former Turing Pharmaceuticals CEO Martin Shkreli (C) leaves court with his lawyer Benjamin Brafman (L) in New York on Feb. 3, 2016. Shkreli, who has become the poster child of pharmaceutical-industry greed after hiking the price of an anti-infection drug by more than 5,000 percent, is scheduled to appear at a congressional hearing on Thursday. AP Photo/Seth Wenig

NEW YORK—Pharmaceutical honcho Martin Shkreli has been banished to solitary confinement amid allegations he was running his drug company from federal prison using a contraband smartphone, a person familiar with the matter told The Associated Press.

Shkreli was moved to solitary confinement at the Fort Dix, New Jersey, facility on March 7 and is likely to remain there while his alleged conduct is being investigated, the person said. The person wasn’t authorized to discuss the matter publicly and spoke on condition of anonymity.